Summarized by Masters of Longevity from PR Newswire.
Report on a presented proof‑of‑concept using CTCF-protected cfDNA Capture-Seq to detect early stage solid cancers and validate findings in blinded cohorts.
Key Takeaways
- Capture-Seq isolated CTCF-protected plasma ctDNA and produced sequencing signals absent in healthy controls.
- In the first cohort the method detected 49 of 49 cancers with no false positives reported.
- A second blinded cohort validated results by detecting 13 of 14 later stage cancers with additional healthy controls.
